International Activities

　　On August 1, 2017, 4 members Mr. Pimentel, President of INPI, Mr. Burlandy, Director of Administration and Planning (concurrently serving as Vice-President) of INPI, Mr. Barusiel, Director of Trademarks, Design, and Geographical Indication, and Mr. Morilla, Director of Patents, visited JIPA together with officials of JETRO and JPO. They had an opinion exchange meeting with Mr. Kuji, Executive Director of JIPA, Mr. Kato, Managing Director of JIPA, Mr. Ogawa, chairman of the First International Committee (Nippon Telegraph and Telephone Corporation), Mr. Sako, chairman of the Pharmaceuticals and Biotechnology Committee (Chugai Pharmaceutical Co., Ltd.), Mr. Omi, chairman of the Trademarks Committee (NTT DATA Corporation), and other 9 members from JIPA.

　　First, JIPA introduced our history, organization, membership, main activities such as policy projects and expert committees, opinion submission, network with other IP-related institutes, and the like, to help INPI to better understand the relationship between JIPA and JPO and our involvement in IP policy, which were INPI's concerns before the meeting.

　　Then, a free discussion was held focusing around questionnaires from respective expert committees sent to INPI in advance. INPI gave a detailed explanation of the relationship between INPI and the National Health Surveillance Agency of Brazil (ANVISA) with respect to pharmaceutical-related applications, progress of accession to the Madrid Protocol, Patent Examination Highway (PPH), and other topics. The visitors actively exchanged opinions with the participants from the committees.